Key facts
- This page summarizes Ivor Elrifi's Form 4 filing for Tiziana Life Sciences Ltd (TLSA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Sep 2026, 17:13.
Ivor Elrifi - 15 Aug 2026 Form 4 Insider Report for Tiziana Life Sciences Ltd (TLSA)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- TLSA
- Reported as of
- 15 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Sep 2026, 17:13:13 UTC
- Prior SEC filing
- 06 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ivor Elrifi
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ivor Elrifi filed Form 4 for Tiziana Life Sciences Ltd (TLSA) on 29 Sep 2026.
Change
- Previous filing in this sequence was filed on 06 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002136241
Primary reporting owner
Elrifi Ivor
- Relationship
- Chief Executive Officer
- Address
- 535 BOYLSTON STREET, BOSTON
- Signature
- /s/ Ivor Elrifi
- Signature date
- 29 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSA
transaction
COMMON STOCK
Options Exercise
- Transaction value
- Shares
- +1,050,000
- Change %
- +22%
- Price
- Shares after
- 5,843,684
- Date
- 15 Aug 2026
- Ownership
- By trust
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TLSA
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -1,050,000
- Change %
- -33%
- Price
- Shares after
- 2,100,000
- Date
- 15 Aug 2026
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
- 1,050,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock.
Footnote F2
The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028.